Mackenzie Financial Corp trimmed its stake in The Clorox Company (NYSE:CLX – Free Report) by 67.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 53,252 shares of the company’s stock after selling 109,811 shares during the quarter. Mackenzie Financial Corp’s holdings in Clorox were worth $7,593,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Tyler Stone Wealth Management purchased a new stake in shares of Clorox in the second quarter worth approximately $25,000. Strategic Investment Solutions Inc. IL acquired a new position in Clorox in the first quarter worth approximately $31,000. Fortitude Family Office LLC acquired a new position in Clorox in the fourth quarter worth approximately $29,000. First Capital Advisors Group LLC. acquired a new position in Clorox in the second quarter worth approximately $35,000. Finally, Hartford Financial Management Inc. increased its holdings in Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after buying an additional 93 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms recently commented on CLX. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. The Goldman Sachs Group began coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday. Citigroup lowered their price target on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $148.63.
Clorox Stock Up 0.3 %
CLX opened at $143.58 on Friday. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The stock has a market capitalization of $17.82 billion, a price-to-earnings ratio of 227.90, a P/E/G ratio of 2.22 and a beta of 0.43. The business has a 50 day moving average of $149.99 and a 200-day moving average of $141.79.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the business earned $0.98 earnings per share. Clorox’s revenue for the quarter was up 16.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.34%. Clorox’s dividend payout ratio is 761.90%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Canada Bond Market Holiday: How to Invest and Trade
- Comprehensive Analysis of PayPal Stock
- What is a Secondary Public Offering? What Investors Need to Know
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.